Browsing by Subject
Ara mostrant els elements 1-17 d 17
-
Acquired cancer cell resistance to T cell bispecific antibodies and CAR T targeting HER2 through JAK2 down-modulation
(Nature Research, 2021-02-23) -
AXL – a new player in resistance to HER2 blockade
(Elsevier, 2023-12) -
BRCA1 intronic Alu elements drive gene rearrangements and PARP inhibitor resistance
(Springer Nature, 2019-12-11) -
Cell Plasticity-Related Phenotypes and Taxanes Resistance in Castration-Resistant Prostate Cancer
(Frontiers Media, 2020-11-02) -
Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours
(Nature Publishing Group, 2019-03) -
Comprehensive Characterization of the Mutational Landscape in Localized Anal Squamous Cell Carcinoma
(Elsevier, 2020-07-01) -
High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer
(Nature Portfolio, 2022-09-07) -
Hitting the brakes on autophagy for overcoming acquired resistance in triple negative breast cancer
(AME Publishing Company, 2020-07) -
Multiple low dose therapy as an effective strategy to treat EGFR inhibitor-resistant NSCLC tumours
(Nature Research, 2020-06-22) -
Targeting HER2-AXL heterodimerization to overcome resistance to HER2 blockade in breast cancer
(American Association for the Advancement of Science, 2022-05-20) -
Targeting mTOR to overcome resistance to hormone and CDK4/6 inhibitors in ER-positive breast cancer models
(Nature Portfolio, 2023-02-15) -
The Second Generation Antibody-Drug Conjugate SYD985 Overcomes Resistances to T-DM1
(MDPI, 2020-03-13)